Vincent M. Crowley

1.9k total citations · 1 hit paper
22 papers, 1.1k citations indexed

About

Vincent M. Crowley is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Vincent M. Crowley has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Vincent M. Crowley's work include Heat shock proteins research (11 papers), Peptidase Inhibition and Analysis (7 papers) and Click Chemistry and Applications (5 papers). Vincent M. Crowley is often cited by papers focused on Heat shock proteins research (11 papers), Peptidase Inhibition and Analysis (7 papers) and Click Chemistry and Applications (5 papers). Vincent M. Crowley collaborates with scholars based in United States, Germany and Japan. Vincent M. Crowley's co-authors include Benjamin F. Cravatt, Melissa M. Dix, Thomas Wucherpfennig, Xiaoyu Zhang, Brian S. J. Blagg, Anuj Khandelwal, Raquel L. Lieberman, Dustin J. E. Huard, Radu M. Suciu and Sanket J. Mishra and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

In The Last Decade

Vincent M. Crowley

22 papers receiving 1.1k citations

Hit Papers

Electrophilic PROTACs that degrade nuclear proteins by en... 2019 2026 2021 2023 2019 100 200 300

Peers

Vincent M. Crowley
Mathew P. Martin United Kingdom
Roberta Pireddu United States
Travis Stams United States
Kurt W. Vogel United States
Kenneth M. Comess United States
Kate F. Byth United States
Mathew P. Martin United Kingdom
Vincent M. Crowley
Citations per year, relative to Vincent M. Crowley Vincent M. Crowley (= 1×) peers Mathew P. Martin

Countries citing papers authored by Vincent M. Crowley

Since Specialization
Citations

This map shows the geographic impact of Vincent M. Crowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent M. Crowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent M. Crowley more than expected).

Fields of papers citing papers by Vincent M. Crowley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent M. Crowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent M. Crowley. The network helps show where Vincent M. Crowley may publish in the future.

Co-authorship network of co-authors of Vincent M. Crowley

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent M. Crowley. A scholar is included among the top collaborators of Vincent M. Crowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent M. Crowley. Vincent M. Crowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Shuxia, et al.. (2023). Elucidation of novel TRAP1-Selective inhibitors that regulate mitochondrial processes. European Journal of Medicinal Chemistry. 258. 115531–115531. 11 indexed citations
2.
Eisa, Nada H., Vincent M. Crowley, Asif Elahi, et al.. (2023). Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer. iScience. 26(12). 108308–108308. 11 indexed citations
3.
Eisa, Nada H., Vincent M. Crowley, Asif Elahi, et al.. (2023). Abstract 2272: Targeting the chaperone Hsp90 to activate the immune system and eradicate the triple negative breast cancer. Cancer Research. 83(7_Supplement). 2272–2272. 1 indexed citations
4.
Crowley, Vincent M., et al.. (2023). Enniatin A Analogues as Novel Hsp90 Inhibitors that Modulate Triple-Negative Breast Cancer. ACS Medicinal Chemistry Letters. 14(12). 1785–1790. 4 indexed citations
5.
Crowley, Vincent M., et al.. (2021). Chemical proteomic identification of functional cysteines with atypical electrophile reactivities. Tetrahedron Letters. 67. 152861–152861. 7 indexed citations
6.
Abbasov, Mikail E., Madeline E. Kavanagh, Taka-Aki Ichu, et al.. (2021). A proteome-wide atlas of lysine-reactive chemistry. Nature Chemistry. 13(11). 1081–1092. 156 indexed citations
7.
Zhang, Xiaoyu, Christie L. Eissler, Vincent M. Crowley, et al.. (2021). DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras. Journal of the American Chemical Society. 143(13). 5141–5149. 119 indexed citations
8.
Crowley, Vincent M., Marvin Thielert, & Benjamin F. Cravatt. (2021). Functionalized Scout Fragments for Site-Specific Covalent Ligand Discovery and Optimization. ACS Central Science. 7(4). 613–623. 35 indexed citations
9.
Zhang, Xiaoyu, Vincent M. Crowley, Thomas Wucherpfennig, Melissa M. Dix, & Benjamin F. Cravatt. (2019). Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16. Nature Chemical Biology. 15(7). 737–746. 324 indexed citations breakdown →
10.
Vinogradova, Ekaterina V., Radu M. Suciu, Vincent M. Crowley, et al.. (2019). The Proteome‐Wide Potential for Reversible Covalency at Cysteine. Angewandte Chemie. 131(33). 11507–11511. 6 indexed citations
11.
Vinogradova, Ekaterina V., Radu M. Suciu, Vincent M. Crowley, et al.. (2019). The Proteome‐Wide Potential for Reversible Covalency at Cysteine. Angewandte Chemie International Edition. 58(33). 11385–11389. 44 indexed citations
12.
Que, Nanette L. S., Vincent M. Crowley, Adam S. Duerfeldt, et al.. (2018). Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding. Journal of Medicinal Chemistry. 61(7). 2793–2805. 37 indexed citations
13.
Huard, Dustin J. E., Vincent M. Crowley, Yuhong Du, et al.. (2018). Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma. ACS Chemical Biology. 13(4). 933–941. 22 indexed citations
14.
Stothert, Andrew R., Xiaolan Tang, Vincent M. Crowley, et al.. (2017). Isoform-selective Hsp90 inhibition rescues model of hereditary open-angle glaucoma. Scientific Reports. 7(1). 17951–17951. 25 indexed citations
15.
Crowley, Vincent M., Dustin J. E. Huard, Raquel L. Lieberman, & Brian S. J. Blagg. (2017). Second Generation Grp94‐Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer. Chemistry - A European Journal. 23(62). 15775–15782. 39 indexed citations
16.
Khandelwal, Anuj, Vincent M. Crowley, & Brian S. J. Blagg. (2017). Resorcinol-Based Grp94-Selective Inhibitors. ACS Medicinal Chemistry Letters. 8(10). 1013–1018. 29 indexed citations
17.
Khandelwal, Anuj, Vincent M. Crowley, & Brian S. J. Blagg. (2015). Natural Product Inspired N‐Terminal Hsp90 Inhibitors: From Bench to Bedside?. Medicinal Research Reviews. 36(1). 92–118. 83 indexed citations
18.
Stothert, Andrew R., Dustin J. E. Huard, Sarah N. Fontaine, et al.. (2014). Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma. Human Molecular Genetics. 23(24). 6470–6480. 39 indexed citations
19.
Muth, Aaron, Vincent M. Crowley, Anuj Khandelwal, et al.. (2014). Development of radamide analogs as Grp94 inhibitors. Bioorganic & Medicinal Chemistry. 22(15). 4083–4098. 24 indexed citations
20.
Smith, David, et al.. (2013). An Efficient Synthesis of 4(5)-Benzyl-l-histidines Employing Catalytic Transfer Hydrogenolysis at Elevated Temperatures. Synthesis. 46(4). 515–521. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026